SG11201810192TA - Antibacterial compositions - Google Patents

Antibacterial compositions

Info

Publication number
SG11201810192TA
SG11201810192TA SG11201810192TA SG11201810192TA SG11201810192TA SG 11201810192T A SG11201810192T A SG 11201810192TA SG 11201810192T A SG11201810192T A SG 11201810192TA SG 11201810192T A SG11201810192T A SG 11201810192TA SG 11201810192T A SG11201810192T A SG 11201810192TA
Authority
SG
Singapore
Prior art keywords
international
pct
wellington
english
unless
Prior art date
Application number
SG11201810192TA
Inventor
David Francis Ackerley
Janine Naomi Copp
Original Assignee
Janine Naomi Copp
Victoria Link Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janine Naomi Copp, Victoria Link Ltd filed Critical Janine Naomi Copp
Publication of SG11201810192TA publication Critical patent/SG11201810192TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property MD Organization 1101111011101111011111 1111111111001111111111111111111III11EHIM III1 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\"1 WO 2017/200396 Al 23 November 2017 (23.11.2017) WIPO I PCT (51) International Patent Classification: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, A61K 31/165 (2006.01) A61P 31/04 (2006.01) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, A61K 47/42 (2017.01) TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/NZ2017/050065 kind of regional protection available): ARIPO (BW, GH, (22) International Filing Date: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, 18 May 2017 (18.05.2017) UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (26) Publication Language: English MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: KM, ML, MR, NE, SN, TD, TG). 720296 18 May 2016 (18.05.2016) NZ Published: (72) Inventors; and — with international search report (Art. 21(3)) (71) Applicants: ACKERLEY, David Francis [NZ/NZ]; 29 Collier Avenue, Karori, Wellington, 6012 (NZ). COPP, Ja- nine Naomi [NZ/NZ]; 77 Pine Hill Road, Ruby Bay, Nel- son, 7005 (NZ). (74) Agent: CATALYST INTELLECTUAL PROPERTY; _ Level 5, 111 Customhouse Quay, Wellington, 6011 (NZ). = Designated States (unless otherwise indicated, for every (81) kind of national protection available): AE, AG, AL, AM, = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, _ CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, = HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, = = MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, Title: ANTIBACTERIAL COMPOSITIONS (54) = = = = = FIGURE 3 poiymyxin B (111\11) = = 0 0,126 0.25 03 1 0.00 100 97 97 92 58 = = = — 0.31 98 95 88 44 0.63 97 92 79 A = .. t25 96 89 72 _ 1-1 0 2.50 89 '79 58 V::+ 5.00 54 49 , ' • 0 \ en 10.00 46 , 0 0 ei 20.00 46 41 ai \ IN ,—, © el (57) : The present invention provides compositions, including pharmaceutical compositions, comprising a salicylamide com- ,, m , pound and an agent that increases the permeability of a bacterial cell membrane for use in treating or preventing bacterial infections.
SG11201810192TA 2016-05-18 2017-05-18 Antibacterial compositions SG11201810192TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ72029616 2016-05-18
PCT/NZ2017/050065 WO2017200396A1 (en) 2016-05-18 2017-05-18 Antibacterial compositions

Publications (1)

Publication Number Publication Date
SG11201810192TA true SG11201810192TA (en) 2018-12-28

Family

ID=60326325

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810192TA SG11201810192TA (en) 2016-05-18 2017-05-18 Antibacterial compositions

Country Status (8)

Country Link
US (1) US20190274978A1 (en)
EP (1) EP3458041A4 (en)
JP (1) JP2019522677A (en)
CN (1) CN109475515A (en)
AU (1) AU2017267248A1 (en)
CA (1) CA3024561A1 (en)
SG (1) SG11201810192TA (en)
WO (1) WO2017200396A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201805453D0 (en) * 2018-04-03 2018-05-16 Antibiotx As Novel use
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
CN110564653B (en) * 2019-10-09 2020-07-03 常州新东化工发展有限公司 Klebsiella michiganensis and application thereof in production of1, 3-propylene glycol
CN111518147A (en) * 2020-04-29 2020-08-11 华东理工大学 Benzoylanilide compound and application thereof in preparing sensitizer of pseudomonas aeruginosa inhibitor
CN117064881B (en) * 2023-09-27 2024-03-15 南京农业大学 Application of nitazoxanide in preparing potentiator for resisting MCR-1 and NDM-5 positive strains
CN117105810B (en) * 2023-10-23 2024-02-09 中国农业大学 Compound with broad-spectrum antibacterial activity and antibacterial composition thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101695744B1 (en) * 2014-10-16 2017-01-12 한국생명공학연구원 Antimicrobial method by synergistic effect of ciclopirox and polymyxin B against gram-negative bacteria

Also Published As

Publication number Publication date
JP2019522677A (en) 2019-08-15
US20190274978A1 (en) 2019-09-12
CA3024561A1 (en) 2017-11-23
AU2017267248A1 (en) 2018-12-06
EP3458041A4 (en) 2020-01-15
WO2017200396A1 (en) 2017-11-23
CN109475515A (en) 2019-03-15
EP3458041A1 (en) 2019-03-27

Similar Documents

Publication Publication Date Title
SG11201810192TA (en) Antibacterial compositions
SG11201903697WA (en) Liver organoid compositions and methods of making and using same
SG11201900135YA (en) N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
SG11201805888SA (en) Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201810454YA (en) Use of an anti-pd-1 antibody in combination with an anti-cd30 antibody in lymphoma treatment
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201809976PA (en) Protection of plant extracts and compounds from degradation
SG11201904535VA (en) Prevention and treatment of bone and cartilage damage or disease
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201805001UA (en) Method of treating influenza a
SG11201407812SA (en) Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy
SG11201808525UA (en) Anti-complement factor bb antibodies and uses thereof
SG11201805771XA (en) Systems and methods for preparation of platelets
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201810786RA (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
SG11201804220SA (en) Activated stem cells and systemic treatment methods for infected wounds
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201810428PA (en) Composition and methods for microbiota therapy